Literature DB >> 19237648

Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.

Vanessa Mathys1, René Wintjens, Philippe Lefevre, Julie Bertout, Amit Singhal, Mehdi Kiass, Natalia Kurepina, Xiao-Ming Wang, Barun Mathema, Alain Baulard, Barry N Kreiswirth, Pablo Bifani.   

Abstract

The emergence of Mycobacterium tuberculosis resistant to first-line antibiotics has renewed interest in second-line antitubercular agents. Here, we aimed to extend our understanding of the mechanisms underlying para-aminosalicylic acid (PAS) resistance by analysis of six genes of the folate metabolic pathway and biosynthesis of thymine nucleotides (thyA, dfrA, folC, folP1, folP2, and thyX) and three N-acetyltransferase genes [nhoA, aac(1), and aac(2)] among PAS-resistant clinical isolates and spontaneous mutants. Mutations in thyA were identified in only 37% of the clinical isolates and spontaneous mutants. Overall, 24 distinct mutations were identified in the thyA gene and 3 in the dfrA coding region. Based on structural bioinformatics techniques, the altered ThyA proteins were predicted to generate an unfolded or dysfunctional polypeptide. The MIC was determined by Bactec/Alert and dilution assay. Sixty-three percent of the PAS-resistant isolates had no mutations in the nine genes considered in this study, revealing that PAS resistance in M. tuberculosis involves mechanisms or targets other than those pertaining to the biosynthesis of thymine nucleotides. The alternative mechanism(s) or pathway(s) associated with PAS resistance appears to be PAS concentration dependent, in marked contrast to thyA-mutated PAS-resistant isolates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237648      PMCID: PMC2681553          DOI: 10.1128/AAC.01197-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  PoPMuSiC, rationally designing point mutations in protein structures.

Authors:  J M Kwasigroch; D Gilis; Y Dehouck; M Rooman
Journal:  Bioinformatics       Date:  2002-12       Impact factor: 6.937

2.  Cycloserine: antituberculous activity in vitro and in the experimental animal.

Authors:  W STEENKEN; E WOLINSKY
Journal:  Am Rev Tuberc       Date:  1956-04

Review 3.  Modulation of mutagenesis by deoxyribonucleotide levels.

Authors:  B A Kunz; S E Kohalmi
Journal:  Annu Rev Genet       Date:  1991       Impact factor: 16.830

4.  Effects of antimicrobial agents on the tubercle bacillus and on experimental tuberculosis.

Authors:  W STEENKEN; E WOLINSKY
Journal:  Am J Med       Date:  1950-11       Impact factor: 4.965

5.  Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.

Authors:  Alessandro De Logu; Valentina Onnis; Barbara Saddi; Cenzo Congiu; Maria Laura Schivo; Maria Teresa Cocco
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

Review 6.  Molecular epidemiology of tuberculosis: current insights.

Authors:  Barun Mathema; Natalia E Kurepina; Pablo J Bifani; Barry N Kreiswirth
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

7.  Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

Authors:  G P Morlock; J T Crawford; W R Butler; S E Brim; D Sikes; G H Mazurek; C L Woodley; R C Cooksey
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

8.  The role of protein dynamics in thymidylate synthase catalysis: variants of conserved 2'-deoxyuridine 5'-monophosphate (dUMP)-binding Tyr-261.

Authors:  Zachary Newby; Tom T Lee; Richard J Morse; Yaoquan Liu; Lu Liu; Prasanna Venkatraman; Daniel V Santi; Janet S Finer-Moore; Robert M Stroud
Journal:  Biochemistry       Date:  2006-06-20       Impact factor: 3.162

9.  The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.

Authors:  Jyothi Rengarajan; Christopher M Sassetti; Vera Naroditskaya; Alexander Sloutsky; Barry R Bloom; Eric J Rubin
Journal:  Mol Microbiol       Date:  2004-07       Impact factor: 3.501

10.  Genome-wide analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial strains.

Authors:  Michaela M Gutacker; James C Smoot; Cristi A Lux Migliaccio; Stacy M Ricklefs; Su Hua; Debby V Cousins; Edward A Graviss; Elena Shashkina; Barry N Kreiswirth; James M Musser
Journal:  Genetics       Date:  2002-12       Impact factor: 4.562

View more
  53 in total

1.  Role of mutations in dihydrofolate reductase DfrA (Rv2763c) and thymidylate synthase ThyA (Rv2764c) in Mycobacterium tuberculosis drug resistance.

Authors:  Claudio U Köser; Richard N Veerapen-Pierce; David K Summers; John A C Archer
Journal:  Antimicrob Agents Chemother       Date:  2010-10       Impact factor: 5.191

2.  N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis.

Authors:  Thulasi Warrier; Kanishk Kapilashrami; Argyrides Argyrou; Thomas R Ioerger; David Little; Kenan C Murphy; Madhumitha Nandakumar; Suna Park; Ben Gold; Jianjie Mi; Tuo Zhang; Eugenia Meiler; Mike Rees; Selin Somersan-Karakaya; Esther Porras-De Francisco; Maria Martinez-Hoyos; Kristin Burns-Huang; Julia Roberts; Yan Ling; Kyu Y Rhee; Alfonso Mendoza-Losana; Minkui Luo; Carl F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

3.  Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.

Authors:  Behnoush Hajian; Eric Scocchera; Carolyn Shoen; Jolanta Krucinska; Kishore Viswanathan; Narendran G-Dayanandan; Heidi Erlandsen; Alexavier Estrada; Katarína Mikušová; Jana Korduláková; Michael Cynamon; Dennis Wright
Journal:  Cell Chem Biol       Date:  2019-03-28       Impact factor: 8.116

Review 4.  Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis.

Authors:  Kelly E Dooley; Carole D Mitnick; Mary Ann DeGroote; Ekwaro Obuku; Vera Belitsky; Carol D Hamilton; Mamodikoe Makhene; Sarita Shah; James C M Brust; Nadza Durakovic; Eric Nuermberger
Journal:  Clin Infect Dis       Date:  2012-05-21       Impact factor: 9.079

5.  para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.

Authors:  Jun Zheng; Eric J Rubin; Pablo Bifani; Vanessa Mathys; Vivian Lim; Melvin Au; Jichan Jang; Jiyoun Nam; Thomas Dick; John R Walker; Kevin Pethe; Luis R Camacho
Journal:  J Biol Chem       Date:  2013-06-18       Impact factor: 5.157

Review 6.  Antibiotic resistance mechanisms in M. tuberculosis: an update.

Authors:  Liem Nguyen
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

Review 7.  Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.

Authors:  Devan Jaganath; H Simon Schaaf; Peter R Donald
Journal:  J Antimicrob Chemother       Date:  2017-07-01       Impact factor: 5.790

8.  Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria.

Authors:  Karine Soetaert; Céline Rens; Xiao-Ming Wang; Jacqueline De Bruyn; Marie-Antoinette Lanéelle; Françoise Laval; Anne Lemassu; Mamadou Daffé; Pablo Bifani; Véronique Fontaine; Philippe Lefèvre
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

Review 9.  Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.

Authors:  Yusuke Minato; Joshua M Thiede; Shannon Lynn Kordus; Edward J McKlveen; Breanna J Turman; Anthony D Baughn
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

Review 10.  Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.

Authors:  Claudio U Köser; Silke Feuerriegel; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.